Recommended Topic Related To:

Naftin Gel

"The U.S. Food and Drug Administration today approved Sivextro (tedizolid phosphate), a new antibacterial drug, to treat adults with skin infections.

Sivextro is approved to treat patients with acute bacterial skin and skin structure infecti"...

Naftin Gel

PATIENT INFORMATION

The patient should be told to:

  1. Avoid the use of occlusive dressings or wrappings unless otherwise directed by the physician.
  2. Keep Naftin® (naftifine) Gel, 1% away from the eyes, nose, mouth and other mucous membranes.

Last reviewed on RxList: 6/11/2008
This monograph has been modified to include the generic and brand name in many instances.

A A A

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Women's Health

Find out what women really need.


NIH talks about Ebola on WebMD

From WebMD